Most European travellers heading to sub-tropical regions know to make sure they're up to date on their vaccinations. While ...

The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...

HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

The EMA has lifted restrictions on the chikungunya vaccine in people 65 and older, while warning that it should be used only ...

July, 11 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating ...

Valneva (NASDAQ:VALN) said on Friday that the European Medicines Agency (EMA) has lifted the suspension on its chikungunya ...

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...

The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...